NBME 22 Yes; the patient may wish to consider the money's influence on the physician's recommendation (NBME Answers)

need help with your account or subscription? click here to email us (or see the contact page)

Retired NBME 22 Answers

nbme22/Block 3/Question#10 (reveal difficulty score)
A 50-year-old man comes to the physician for ...
Yes; the patient may wish to consider the money's influence on the physician's recommendation 🔍 / 📺 / 🌳 / 📖
tags:

+2 upvote downvote
submitted by nootnootpenguinn(9)

get full access to all content ⋅ pick a username

I actually picked "No; the arrangement is contractual between the physician and the company, not the patient." However, after some FA review (2019, page 264), informed consent include disclosure, which includes the the incentive that the company is offering the physician.

I hope this helps!

get full access to all content ⋅ pick a username

l0ud_minority I thought we weren't supposed to accept monies from companies. +

+0 upvote downvote
submitted by ∗djtallahassee(28)

get full access to all content ⋅ pick a username

Wouldn't telling the patient about the referral do more harm than good?

Pt considers it a bribe and leaves
Ruins study due to placbo effects
Puts doc/hospital at risk for potential legal hassle.

I guess maybe I read it as a study when it really is just a referral but its not that much of a leap to think that this "experimental"" treatment is part of a study

get full access to all content ⋅ pick a username

drzed I think this more of an ethical question (not a legal, or study design problem). Ethically, between the choices of being transparent with your patient, or not, the choice would be to disclose. Disclosing and offering to share would come across as a bribe, so that is less favorable than simply being transparent and putting the patient in charge of their decision. +

+0 upvote downvote
submitted by sunny(9)

get full access to all content ⋅ pick a username

WHY NOT YES,and then share the money with the patieny so he doesn't doubt your motives.

get full access to all content ⋅ pick a username

ergogenic22 because then it is as if you are paying the patient to enroll in the experimental treatment +

ergogenic22 because then it is as if you are paying the patient to enroll in the experimental treatment, which I don't know why that would be wrong +

dubywow Bribery is only good for doctors. Can't bribe patients. That's illegal. Kind of like how NCAA gets paid a lot, but student athletes get nadda. Still the TLDR is it always ethical to disclose financial incentives when they relate to anything that may affect your decision on how to treat a patient. +2

Must-See Comments from nbme22

sacredazn on Unrearranged immunoglobulin gene
seagull on Decreased binding of RNA polymerase
seagull on Anticholinergic
mcl on Area labeled ‘D’
liverdietrying on Release of stored thyroid hormone from a ...
kernicterusthefrog on Displacement
keycompany on Negative nitrogen balance
joha961 on Displacement
imgdoc on Area labeled ‘C’ (Abducens nucleus, right)
alwaysanonymous on 25 mL/cm H2O
drdoom on 1 in 600
seagull on Glutamine
yotsubato on Phase variation
bubbles on Acute retroviral infection